GRAND-MAL SEIZURES AS A COMPLICATION OF TREATMENT WITH PEFLOXACIN IN PATIENTS WITH CIRRHOSIS - A REPORT OF 3 CASES

被引:4
作者
CHAPUIS, L
CADRANEL, JF
NORDMANN, P
HAGEGE, H
GARGOT, D
BERNARD, B
BUFFET, C
VALLA, D
OPOLON, P
机构
[1] HOP LA PITIE SALPETRIERE,SERV HEPATOGASTROENTEROL,F-75651 PARIS,FRANCE
[2] HOP LA PITIE SALPETRIERE,SERV BACTERIOVIROL,F-75651 PARIS,FRANCE
[3] HOP BICETRE,SERV MALAD FOIE & APPAREIL DIGEST,F-94275 LE KREMLIN BICETR,FRANCE
关键词
PEFLOXACINE; FLUOROQUINOLONE; SEIZURES; CIRRHOSIS;
D O I
10.1016/S0168-8278(05)80546-X
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
In this paper, three cases of grand mal seizures are reported as a complication of pefloxacin at usual doses (400 mg twice a day) in patients with cirrhosis. Grand mal seizures occurred from 12 h to 8 days after the onset of pefloxacin treatment. In 1 case, seizures recurred after inadvertent rechallenge with the drug. Elevated pefloxacin serum levels were demonstrated in 2 cases. Brain computed tomography in all 3 cases and cerebrospinal fluid examination showed normal results. No etiology other than pefloxacin overdose was found. After pefloxacin withdrawal, no recurrence of seizures were observed. Therefore, when pefloxacin treatment is indicated for cirrhotic patients, a reduced dosage and/or careful monitoring of pefloxacin serum levels should be recommended.
引用
收藏
页码:383 / 384
页数:2
相关论文
共 10 条
[1]  
BALL P, 1989, CLIN INVEST MED, V12, P28
[2]   ORAL PHARMACOKINETICS AND ASCITIC FLUID PENETRATION OF PEFLOXACIN IN CIRRHOSIS [J].
CARDEY, J ;
SILVAIN, C ;
BOUQUET, S ;
BREUX, JP ;
BECQGIRAUDON, B ;
FOURTILLAN, JP ;
BEAUCHANT, M .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 33 (05) :469-472
[3]   PEFLOXACIN KINETICS IN CIRRHOSIS [J].
DANAN, G ;
MONTAY, G ;
CUNCI, R ;
ERLINGER, S .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (04) :439-442
[4]   TRANSFER KINETICS OF PEFLOXACIN INTO CEREBROSPINAL-FLUID AFTER ONE HOUR IV INFUSION OF 400-MG IN MAN [J].
DOW, J ;
CHAZAL, J ;
FRYDMAN, AM ;
JANNY, P ;
WOEHRLE, R ;
DJEBBAR, F ;
GAILLOT, J .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 17 :81-87
[5]   PEFLOXACIN - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE [J].
GONZALEZ, JP ;
HENWOOD, JM .
DRUGS, 1989, 37 (05) :628-668
[6]   NEUROLOGICAL TOXICITY RELATED TO PEFLOXACIN [J].
LUCET, JC ;
TILLY, H ;
LEREBOURS, G ;
GRES, JJ ;
PIGUET, H .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1988, 21 (06) :811-812
[7]   EARLY CHANGES IN THE PERMEABILITY OF THE BLOOD-BRAIN-BARRIER PRODUCED BY TOXINS ASSOCIATED WITH LIVER-FAILURE [J].
MCCLUNG, HJ ;
SLOAN, HR ;
POWERS, P ;
MEROLA, AJ ;
MURRAY, R ;
KERZNER, B ;
POLLACK, JD .
PEDIATRIC RESEARCH, 1990, 28 (03) :227-231
[8]  
ROMANO C, 1989, CLIN NEPHROL, V32, P48
[9]   GRAND MAL EPILEPTIC SEIZURES DURING CIPROFLOXACIN THERAPY [J].
SLAVICH, IL ;
GLEFFE, RF ;
HAAS, EJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (04) :558-559
[10]   EXPERIMENTAL STUDIES OF BLOOD-BRAIN-BARRIER PERMEABILITY IN ACUTE HEPATIC-FAILURE [J].
ZAKI, AEO ;
EDE, RJ ;
DAVIS, M ;
WILLIAMS, R .
HEPATOLOGY, 1984, 4 (03) :359-363